Regeneron Pharmaceuticals Inc. closed 55.21% below its 52-week high of $1,211.20, which the company reached on August 27th.

The global ascites market is experiencing significant growth, driven by the rising prevalence of liver diseases, cancers, and other risk factors like alcohol consumption and hepatitis infections. Key ...

Key factors fueling this trend include increased awareness, improved healthcare infrastructure, and enhanced diagnostic and treatment accessibility. With the prevalence of high myopia projected to ...

This was the stock's fourth consecutive day of gains.

NetworkNewsWire Editorial Coverage NEW YORK, July 7, 2025 /PRNewswire/ -- An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people ...

An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year ...

Regeneron secured accelerated FDA approval for Lynozyfic, a therapy targeting relapsed or refractory multiple myeloma. The drug is approved for patients who’ve tried at least four previous treatments, ...

Jim Parkinson, the designer behind Rolling Stone's iconic logo, has died at 83 after a long battle with Alzheimer’s, his friend confirmed.

Martin's wife, Shay Wright, announced his death June 25, less than a week after she revealed he had made the "brave decision" to enter hospice.

Methodology We sifted through the Finviz stock screener to compile a list of the top S&P 500 stocks that had a high average upside potential of over 20% as of June 24. The stocks are ranked in ...